{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T18:51:21Z","timestamp":1755802281320,"version":"3.44.0"},"reference-count":58,"publisher":"Oxford University Press (OUP)","issue":"17","license":[{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Heilongjiang Chunyan Youth Science and Technology Talent team project","award":["CYQN24009"],"award-info":[{"award-number":["CYQN24009"]}]},{"name":"Fujian Key Laboratory of Medical Bioinformatics","award":["FKLMB-202101"],"award-info":[{"award-number":["FKLMB-202101"]}]},{"DOI":"10.13039\/501100005046","name":"Natural Science Foundation of Heilongjiang Province","doi-asserted-by":"publisher","award":["LH2022F042"],"award-info":[{"award-number":["LH2022F042"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["62101164"],"award-info":[{"award-number":["62101164"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The high heterogeneity of tumor microenvironment (TME) is a key factor affecting immunotherapy. We integrated immunotherapy related scRNA-seq and bulk datasets to analyze the TME, mine key factors and dissect the mechanism in immunotherapy. Analyzing the cell composition of TME in cancer immunotherapy, we revealed key TME cell types, including B cells, CD8+ T cells and fibroblasts. Through cell subsets identification, pseudo-time sequence and functional status analysis of malignant cells, it was found that the functional status of malignant cell was heterogeneous under different immunotherapy conditions. Key cellular interactions in cancer immunotherapy were also revealed. Further, 16 marker genes and 6 marker cell types of cancer immunotherapy were identified, and then gene and cell model were constructed to predict the immunotherapy response of individuals, and the model were evaluated based on multiple independent validation datasets. This study can provide important guidance for improving the efficiency and understanding the mechanism of cancer immunotherapy.<\/jats:p>","DOI":"10.1093\/hmg\/ddaf101","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T16:03:47Z","timestamp":1751040227000},"page":"1446-1457","source":"Crossref","is-referenced-by-count":0,"title":["Single cell analysis of pan-cancer tumor microenvironment in immunotherapy"],"prefix":"10.1093","volume":"34","author":[{"given":"Feng","family":"Li","sequence":"first","affiliation":[{"name":"College of Bioinformatics Science and Technology, Harbin Medical University , 157 Baojian Road, Harbin, Heilongjiang 150081 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Xue","sequence":"additional","affiliation":[{"name":"College of Bioinformatics Science and Technology, Harbin Medical University , 157 Baojian Road, Harbin, Heilongjiang 150081 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liying","family":"Pei","sequence":"additional","affiliation":[{"name":"College of Bioinformatics Science and Technology, Harbin Medical University , 157 Baojian Road, Harbin, Heilongjiang 150081 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Sun","sequence":"additional","affiliation":[{"name":"College of Bioinformatics Science and Technology, Harbin Medical University , 157 Baojian Road, Harbin, Heilongjiang 150081 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Chen","sequence":"additional","affiliation":[{"name":"College of Bioinformatics Science and Technology, Harbin Medical University , 157 Baojian Road, Harbin, Heilongjiang 150081 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifang","family":"Zhang","sequence":"additional","affiliation":[{"name":"College of Bioinformatics Science and Technology, Harbin Medical University , 157 Baojian Road, Harbin, Heilongjiang 150081 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaiyue","family":"Song","sequence":"additional","affiliation":[{"name":"College of Bioinformatics Science and Technology, Harbin Medical University , 157 Baojian Road, Harbin, Heilongjiang 150081 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wensong","family":"Liu","sequence":"additional","affiliation":[{"name":"College of Bioinformatics Science and Technology, Harbin Medical University , 157 Baojian Road, Harbin, Heilongjiang 150081 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quan","family":"Qi","sequence":"additional","affiliation":[{"name":"College of Bioinformatics Science and Technology, Harbin Medical University , 157 Baojian Road, Harbin, Heilongjiang 150081 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Gong","sequence":"additional","affiliation":[{"name":"Harbin Center for Disease Control and Prevention, Harbin Municipal Health Commission , No. 30, Weixing Road, Daowai District, Harbin, Heilongjiang 150026 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[{"name":"Fujian Key Laboratory of Medical Bioinformatics, Department of Bioinformatics, School of Medical Technology and Engineering, Fujian Medical University , No. 1, Xuefu North Road, University New District, Fuzhou , Fujian 350122,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanjun","family":"Xu","sequence":"additional","affiliation":[{"name":"College of Bioinformatics Science and Technology, Harbin Medical University , 157 Baojian Road, Harbin, Heilongjiang 150081 ,","place":["China"]},{"name":"Fujian Key Laboratory of Medical Bioinformatics, Department of Bioinformatics, School of Medical Technology and Engineering, Fujian Medical University , No. 1, Xuefu North Road, University New District, Fuzhou , Fujian 350122,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,6,19]]},"reference":[{"key":"2025082106421299800_ref1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.immuni.2019.12.011","article-title":"Top 10 challenges in cancer immunotherapy","volume":"52","author":"Hegde","year":"2020","journal-title":"Immunity"},{"key":"2025082106421299800_ref2","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1056\/NEJMoa1816714","article-title":"Pembrolizumab plus Axitinib versus sunitinib for advanced renal-cell carcinoma","volume":"380","author":"Rini","year":"2019","journal-title":"N Engl J Med"},{"key":"2025082106421299800_ref3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41571-018-0142-8","article-title":"Cancer immunoediting and resistance to T cell-based immunotherapy","volume":"16","author":"O'Donnell","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"2025082106421299800_ref4","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1097\/HEP.0000000000000673","article-title":"Single-cell dissection of the multicellular ecosystem and molecular features underlying microvascular invasion in HCC","volume":"79","author":"Li","year":"2024","journal-title":"Hepatology"},{"key":"2025082106421299800_ref5","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/s41416-024-02803-7","article-title":"Integrated immuno-transcriptomic analysis of ovarian cancer identifies a four-chemokine-dominated subtype with antitumor immune-active phenotype and favorable prognosis","volume":"131","author":"Zhuo","year":"2024","journal-title":"Br J Cancer"},{"key":"2025082106421299800_ref6","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/s41571-022-00689-z","article-title":"Clinical implications of T cell exhaustion for cancer immunotherapy","volume":"19","author":"Chow","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"2025082106421299800_ref7","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1016\/j.cell.2022.06.018","article-title":"Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy","volume":"185","author":"Luoma","year":"2022","journal-title":"Cell"},{"key":"2025082106421299800_ref8","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41586-019-1906-8","article-title":"B cells are associated with survival and immunotherapy response in sarcoma","volume":"577","author":"Petitprez","year":"2020","journal-title":"Nature"},{"key":"2025082106421299800_ref9","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1158\/0008-5472.CAN-22-2192","article-title":"Space is the place: mapping the cell-cell interactions that predict immunotherapy responses in melanoma","volume":"82","author":"Smalley","year":"2022","journal-title":"Cancer Res"},{"key":"2025082106421299800_ref10","doi-asserted-by":"crossref","first-page":"1908010","DOI":"10.1080\/2162402X.2021.1908010","article-title":"Investigating mechanisms of response or resistance to immune checkpoint inhibitors by Analyzing cell-cell Communications in Tumors before and after programmed cell Death-1 (PD-1) targeted therapy: an integrative analysis using single-cell RNA and bulk-RNA sequencing data","volume":"10","author":"Jiang","year":"2021","journal-title":"Oncoimmunology"},{"key":"2025082106421299800_ref11","doi-asserted-by":"crossref","first-page":"104207","DOI":"10.1016\/j.ebiom.2022.104207","article-title":"Pan-cancer landscape of T-cell exhaustion heterogeneity within the tumor microenvironment revealed a progressive roadmap of hierarchical dysfunction associated with prognosis and therapeutic efficacy","volume":"83","author":"Zhang","year":"2022","journal-title":"EBioMedicine"},{"key":"2025082106421299800_ref12","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.ccell.2021.02.015","article-title":"Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma","volume":"39","author":"Bi","year":"2021","journal-title":"Cancer Cell"},{"key":"2025082106421299800_ref13","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/s41591-021-01323-8","article-title":"A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer","volume":"27","author":"Bassez","year":"2021","journal-title":"Nat Med"},{"key":"2025082106421299800_ref14","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41568-022-00466-1","article-title":"Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities","volume":"22","author":"Laumont","year":"2022","journal-title":"Nat Rev Cancer"},{"key":"2025082106421299800_ref15","doi-asserted-by":"crossref","first-page":"1900508","DOI":"10.1080\/2162402X.2021.1900508","article-title":"Tertiary lymphoid structures and B lymphocytes in cancer prognosis and response to immunotherapies","volume":"10","author":"Jacquelot","year":"2021","journal-title":"Oncoimmunology"},{"key":"2025082106421299800_ref16","doi-asserted-by":"crossref","first-page":"6075","DOI":"10.1158\/1078-0432.CCR-21-0697","article-title":"Role of B cells in responses to checkpoint blockade immunotherapy and overall survival of cancer patients","volume":"27","author":"Kim","year":"2021","journal-title":"Clin Cancer Res"},{"key":"2025082106421299800_ref17","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/s41591-022-01799-y","article-title":"A T cell resilience model associated with response to immunotherapy in multiple tumor types","volume":"28","author":"Zhang","year":"2022","journal-title":"Nat Med"},{"key":"2025082106421299800_ref18","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41571-020-0333-y","article-title":"Tissue-resident memory T cells in breast cancer control and immunotherapy responses","volume":"17","author":"Byrne","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"2025082106421299800_ref19","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41586-019-1922-8","article-title":"B cells and tertiary lymphoid structures promote immunotherapy response","volume":"577","author":"Helmink","year":"2020","journal-title":"Nature"},{"key":"2025082106421299800_ref20","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","article-title":"A guide to cancer immunotherapy: from T cell basic science to clinical practice","volume":"20","author":"Waldman","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"2025082106421299800_ref21","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.cell.2016.04.009","article-title":"Effector T cells abrogate stroma-mediated chemoresistance in ovarian cancer","volume":"165","author":"Wang","year":"2016","journal-title":"Cell"},{"key":"2025082106421299800_ref22","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1158\/0008-5472.CAN-21-4141","article-title":"Cancer-associated fibroblasts suppress CD8+ T-cell infiltration and confer resistance to immune-checkpoint blockade","volume":"82","author":"Jenkins","year":"2022","journal-title":"Cancer Res"},{"key":"2025082106421299800_ref23","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s41573-020-00092-2","article-title":"B cell depletion therapies in autoimmune disease: advances and mechanistic insights","volume":"20","author":"Lee","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"2025082106421299800_ref24","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.actbio.2021.02.026","article-title":"External cues to drive B cell function towards immunotherapy","volume":"133","author":"Stoycheva","year":"2021","journal-title":"Acta Biomater"},{"key":"2025082106421299800_ref25","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1038\/s41596-020-0292-x","article-title":"CellPhoneDB: inferring cell-cell communication from combined expression of multi-subunit ligand-receptor complexes","volume":"15","author":"Efremova","year":"2020","journal-title":"Nat Protoc"},{"key":"2025082106421299800_ref26","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.cmet.2020.04.007","article-title":"Developmental and tumor angiogenesis requires the mitochondria-shaping protein Opa1","volume":"31","author":"Herkenne","year":"2020","journal-title":"Cell Metab"},{"key":"2025082106421299800_ref27","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41590-023-01687-8","article-title":"A second-generation M1-polarized CAR macrophage with antitumor efficacy","volume":"25","author":"Lei","year":"2024","journal-title":"Nat Immunol"},{"key":"2025082106421299800_ref28","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1158\/1078-0432.CCR-19-1321","article-title":"Dendritic cells, the T-cell-inflamed tumor microenvironment, and immunotherapy treatment response","volume":"26","author":"Garris","year":"2020","journal-title":"Clin Cancer Res"},{"key":"2025082106421299800_ref29","article-title":"Galectin-1 fosters an immunosuppressive microenvironment in colorectal cancer by reprogramming CD8(+) regulatory T cells","volume":"118:e2102950118","author":"Cagnoni","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"2025082106421299800_ref30","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1158\/0008-5472.CAN-20-2990","article-title":"Macrophage-based approaches for cancer immunotherapy","volume":"81","author":"Anderson","year":"2021","journal-title":"Cancer Res"},{"key":"2025082106421299800_ref31","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41577-019-0127-6","article-title":"Macrophages as regulators of tumour immunity and immunotherapy","volume":"19","author":"DeNardo","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"2025082106421299800_ref32","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.semcancer.2022.11.008","article-title":"Artificial intelligence for prediction of response to cancer immunotherapy","volume":"87","author":"Yang","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"2025082106421299800_ref33","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s43588-024-00748-8","article-title":"Leveraging pharmacovigilance data to predict population-scale toxicity profiles of checkpoint inhibitor immunotherapy","volume":"5","author":"Yan","year":"2025","journal-title":"Nat Comput Sci"},{"key":"2025082106421299800_ref34","first-page":"0671","article-title":"Proteogenomic characterization of high-grade lung neuroendocrine carcinoma deciphers molecular diversity and potential biomarkers of different histological subtypes in Chinese population","volume":"8","author":"Zhang","year":"2025","journal-title":"Research (Wash D C)"},{"key":"2025082106421299800_ref35","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/s41422-022-00627-9","article-title":"Defined tumor antigen-specific T cells potentiate personalized TCR-T cell therapy and prediction of immunotherapy response","volume":"32","author":"He","year":"2022","journal-title":"Cell Res"},{"key":"2025082106421299800_ref36","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1038\/s41467-022-32570-z","article-title":"Predicting response to immunotherapy in gastric cancer via multi-dimensional analyses of the tumour immune microenvironment","volume":"13","author":"Chen","year":"2022","journal-title":"Nat Commun"},{"key":"2025082106421299800_ref37","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1158\/0008-5472.CAN-15-1737","article-title":"A breakthrough: macrophage-directed cancer immunotherapy","volume":"76","author":"Mills","year":"2016","journal-title":"Cancer Res"},{"key":"2025082106421299800_ref38","doi-asserted-by":"crossref","first-page":"e000967","DOI":"10.1136\/jitc-2020-000967","article-title":"Neuropilin-1: a checkpoint target with unique implications for cancer immunology and immunotherapy","volume":"8","author":"Chuckran","year":"2020","journal-title":"J Immunother Cancer"},{"key":"2025082106421299800_ref39","doi-asserted-by":"crossref","first-page":"D991","DOI":"10.1093\/nar\/gks1193","article-title":"NCBI GEO: archive for functional genomics data sets--update","volume":"41","author":"Barrett","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"2025082106421299800_ref40","doi-asserted-by":"crossref","first-page":"D721","DOI":"10.1093\/nar\/gky900","article-title":"CellMarker: a manually curated resource of cell markers in human and mouse","volume":"47","author":"Zhang","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"2025082106421299800_ref41","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"Hanzelmann","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"2025082106421299800_ref42","doi-asserted-by":"crossref","first-page":"D900","DOI":"10.1093\/nar\/gky939","article-title":"CancerSEA: a cancer single-cell state atlas","volume":"47","author":"Yuan","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"2025082106421299800_ref43","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/nmeth.4402","article-title":"Reversed graph embedding resolves complex single-cell trajectories","volume":"14","author":"Qiu","year":"2017","journal-title":"Nat Methods"},{"key":"2025082106421299800_ref44","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1038\/s41467-018-06300-3","article-title":"Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA","volume":"9","author":"Paulson","year":"2018","journal-title":"Nat Commun"},{"key":"2025082106421299800_ref45","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.cell.2018.10.038","article-title":"Defining T cell states associated with response to checkpoint immunotherapy in melanoma","volume":"175","author":"Sade-Feldman","year":"2018","journal-title":"Cell"},{"key":"2025082106421299800_ref46","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/s41467-021-21177-5","article-title":"Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma","volume":"12","author":"Samur","year":"2021","journal-title":"Nat Commun"},{"key":"2025082106421299800_ref47","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.cell.2018.09.006","article-title":"A cancer cell program promotes T cell exclusion and resistance to checkpoint blockade","volume":"175","author":"Jerby-Arnon","year":"2018","journal-title":"Cell"},{"key":"2025082106421299800_ref48","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/s41591-019-0522-3","article-title":"Clonal replacement of tumor-specific T cells following PD-1 blockade","volume":"25","author":"Yost","year":"2019","journal-title":"Nat Med"},{"key":"2025082106421299800_ref49","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41591-021-01245-5","article-title":"Homozygous BCMA gene deletion in response to anti-BCMA CAR T cells in a patient with multiple myeloma","volume":"27","author":"Da Via","year":"2021","journal-title":"Nat Med"},{"key":"2025082106421299800_ref50","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/j.cell.2020.05.017","article-title":"Intratumoral CD4(+) T cells mediate anti-tumor cytotoxicity in human bladder cancer","volume":"181","author":"Oh","year":"2020","journal-title":"Cell"},{"key":"2025082106421299800_ref51","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/s41467-021-21168-6","article-title":"Single-cell profiling identifies pre-existing CD19-negative subclones in a B-ALL patient with CD19-negative relapse after CAR-T therapy","volume":"12","author":"Rabilloud","year":"2021","journal-title":"Nat Commun"},{"key":"2025082106421299800_ref52","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41591-020-0860-1","article-title":"High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade","volume":"26","author":"Yuen","year":"2020","journal-title":"Nat Med"},{"key":"2025082106421299800_ref53","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.ccell.2021.09.010","article-title":"Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer","volume":"39","author":"Zhang","year":"2021","journal-title":"Cancer Cell"},{"key":"2025082106421299800_ref54","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.cell.2017.09.028","article-title":"Tumor and microenvironment evolution during immunotherapy with nivolumab","volume":"171","author":"Riaz","year":"2017","journal-title":"Cell"},{"key":"2025082106421299800_ref55","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s12276-020-00493-8","article-title":"Genome-wide identification of differentially methylated promoters and enhancers associated with response to anti-PD-1 therapy in non-small cell lung cancer","volume":"52","author":"Cho","year":"2020","journal-title":"Exp Mol Med"},{"key":"2025082106421299800_ref56","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13058-020-01362-y","article-title":"Immuno-priming durvalumab with bevacizumab in HER2-negative advanced breast cancer: a pilot clinical trial","volume":"22","author":"Quintela-Fandino","year":"2020","journal-title":"Breast Cancer Res"},{"key":"2025082106421299800_ref57","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1016\/j.cell.2021.03.030","article-title":"Synthetic lethality-mediated precision oncology via the tumor transcriptome","volume":"184","author":"Lee","year":"2021","journal-title":"Cell"},{"key":"2025082106421299800_ref58","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.1038\/s41467-019-12159-9","article-title":"DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load","volume":"10","author":"Jung","year":"2019","journal-title":"Nat Commun"}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/hmg\/article-pdf\/34\/17\/1446\/63526805\/ddaf101.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/hmg\/article-pdf\/34\/17\/1446\/63526805\/ddaf101.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T10:42:24Z","timestamp":1755772944000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/hmg\/article\/34\/17\/1446\/8169185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,19]]},"references-count":58,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2025,6,19]]},"published-print":{"date-parts":[[2025,8,21]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddaf101","relation":{},"ISSN":["0964-6906","1460-2083"],"issn-type":[{"type":"print","value":"0964-6906"},{"type":"electronic","value":"1460-2083"}],"subject":[],"published-other":{"date-parts":[[2025,9,1]]},"published":{"date-parts":[[2025,6,19]]}}}